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Abstract
There is uncertainty as to the optimal initial management of patients with traumatic acute subdural hematoma, leading to
regional variation in surgical policy. This can be exploited to compare the effect of various management strategies and
determine best practices. This article reports such a comparative effectiveness analysis of a retrospective observational cohort
of traumatic acute subdural hematoma patients in two geographically distinct neurosurgical departments chosen for their – a-
priori defined – diverging treatment preferences. Region A favored a strategy focused on surgical hematoma evacuation,
whereas region B employed a more conservative approach, performing primary surgery less often. Region was used as a
proxy for preferred treatment strategy to compare outcomes between groups, adjusted for potential confounders using
multivariable logistic regression with imputation of missing data. In total, 190 patients were included: 108 from region A and
82 from region B. There were 104 males (54.7%). Matching current epidemiological developments, the median age was
relatively high at 68 years (interquartile range [IQR], 54–76). Baseline characteristics were comparable between regions.
Primary evacuation was performed in 84% of patients in region A and in 65% of patients in region B ( p < 0.01). Mortality was
lower in region A (37% vs. 45%, p = 0.29), as was unfavorable outcome (53% vs. 62%, p = 0.23). The strategy favoring
surgical evacuation was associated with significantly lower odds of mortality (odds ratio [OR]: 0.43; 95% confidence interval
[CI]: 0.21–0.88) and unfavorable outcome (OR: 0.53; 95% CI: 0.27–1.02) 3–9 months post-injury. Therefore, in the aging
population of patients with acute subdural hematoma, a treatment strategy favoring emergency hematoma evacuation might
be associated with lower odds of mortality and unfavorable outcome.
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Introduction
In 1983, Gelpke and colleagues compared survival aftersevere traumatic brain injury (TBI) between two neurosurgical
departments in the Netherlands. They concluded that of the 18%
difference in survival rate between centers, 10.5%, was accounted
for by differences in baseline characteristics, and that the remaining
7.5% could reflect differences in management strategies.1 This
study can be regarded as comparative effectiveness research (CER)
avant la lettre in the field of TBI. CER aims to relate naturally
occurring treatment variation to differences in patient-relevant
outcomes, measured in day-to-day clinical settings and broad
populations.2 This is increasingly recognized as a powerful alter-
native to randomized controlled trials (RCTs).3 Many surgical trials
have been hampered by protracted recruitment periods4,5 and
financial constraints,6 while providing limited benefit to clinical
management.5,7–9 Moreover, CER could be worthwhile because,
partly as a result of current treatment guidelines featuring low class
evidence, considerable between-center differences in the clinical
management of TBI are seen.10–16
‘‘To operate or not?’’ is a burning clinical question every sur-
geon frequently has to answer. In the case of traumatic acute sub-
dural hematoma (ASDH), whether the patient will benefit from
direct surgical evacuation of the hematoma remains a contested
issue. Although prompt surgery has been associated with improved
survival,17–20 reported mortality rates remain high, ranging from
40% to 60% in surgically treated patients of all trauma severities.21
Conversely, it has been suggested that certain patients with a poor
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prognosis may not be treated at all,22,23 and patients with minimal
symptomatology or comatose ASDH patient with a minimal he-
matoma without extracranial explanations for his/her coma can
successfully be treated conservatively.24–27 Conservative treatment
comprises observation, serial neurological examinations, and,
sometimes, placement of an intracranial pressure (ICP) monitor
with non-operative/medical management of intracranial hyperten-
sion when appropriate.
Therefore, the decision to operate or not poses a clinical challenge
for the neurosurgeon, and should preferably be aided by guidelines
based on comparison of treatment regimes. However, RCTs have
never been conducted, and comparative observational cohort studies
with balanced treatment groups are unavailable. The most widely
used surgical guidelines published by the Brain Trauma Foundation
are consequently made up of weak evidence.21 Therefore, clinical
decision making is presently influenced by neurosurgeons’ individ-
ual preferences for, or familiarity with, treatment of traumatic
ASDH. As a result, management strategies vary considerably among
neurosurgical departments, even among those within dedicated level
1 trauma centers with protocolled emergency medicine schemes.10–12
Clearly, there is a need for comparative studies to elucidate the
optimal treatment of traumatic ASDH. As randomized surgical
trials are not practically feasible because of the moral boundaries of
treating physicians, the comparison of cohorts among homogenous
regions managing ASDH in different ways may be the best avail-
able alternative to assess the effectiveness of surgical therapy.
The objective of this study was to compare mortality and func-
tional outcome between an immediate surgical and a conservative,
less surgery-driven approach for the treatment of traumatic ASDH.
Methods
This study was conducted and reported according to the criteria
of the Strengthening the Reporting of Observational Based Studies
(STROBE) statement.28
The Dutch healthcare system and regional
treatment variation
Healthcare in the Netherlands is uniformly accessible to all pa-
tients, with equal distribution of resources among hospitals. Neuro-
surgical care for patients with TBI is provided at 11 level 1 trauma
centers, serving separate areas according to regional referral policies.
Training and licensing are equal among these centers. However,
neurosurgical practices differ across these centers, probably because
of local surgical customs handed down over the years: a recent
survey assessing whether neurosurgeons would perform an operation
on various patients with ASDH showed considerable between-center
variation among Dutch neurosurgeons’ attitudes toward patients with
traumatic ASDH.12 Based on this questionnaire, the centers that
showed the most divergent view on whether to operate acutely or not
in cases reflecting the whole clinical TBI severity spectrum (90.0%
vs. 14.3% for moderate TBI, 90.0% vs. 42.9% for severe TBI) were
chosen before the start of the current study. In both centers, the same
Brain Trauma Foundation guideline-based intensive care unit (ICU)
protocol for (refractory) raised ICP is employed whereas the neu-
rosurgical departments do not employ a surgical protocol (e.g., the
Brain Trauma Foundation guideline).
Study design, setting and population
Two patient cohorts were retrospectively identified at two neu-
rosurgical departments, in geographically separate regions. Neu-
rosurgeons from region A treat TBI patients at two neurosurgically
collaborating hospitals within level 1 trauma centers and advocate
primary surgical treatment of ASDH (through hematoma evacua-
tion with or without decompression). Neurosurgeons from region B
operate in a single level 1 trauma center and opt for surgery less
often, suggesting a more conservative approach.12 Both regions
serve a homogeneous population of *2,000,000 people. Regions A
and B employed 16 and 18 neurosurgeons, respectively.
Eligibility criteria
The Dutch registry system for hospital funding appoints diag-
nosis and treatment codes to all patients visiting a hospital. Using
this system as a screening tool, we consecutively identified all pa-
tients treated by a neurosurgeon for TBI between 2008 and 2012 in
both regions. Thereafter, the national trauma registry was checked
for any missed inclusions.29 A broad set of inclusion criteria was
applied: patients were included if they had sustained brain injury
with direct presentation to the emergency room, were >16 years of
age, and showed a hyperdense, crescent shaped lesion – indicative
of an ASDH – on the computed tomography (CT) scan. Exclusion
criteria were penetrating injury, non-traumatic ASDH, ASDH sec-
ondary to an earlier procedure, and presenting with concomitant
intracranial focal lesions (i.e., intracerebral hematoma or epidural
hematoma) that required emergency surgery. Patients withheld from
treatment because of severe comorbidity or because they were
deemed unsalvageable were also excluded on the premises that the
outcome would have been the same regardless of treatment.
Variables
Data from electronic patient files were gathered on demograph-
ics, medical history, use of anticoagulants or antiplatelet agents,
injury-related variables, radiological variables, treatment variables,
complications, and outcome variables.
Injury-related variables included trauma mechanism, first emer-
gency room Glasgow Coma Scale (GCS) score, focal neurological
symptoms (paresis, aphasia, or cranial nerve deficit), pupillary light
reflex, clinical deterioration (i.e., a decrease of >1 point on the GCS,
new abnormal pupillary light reflex, or new focal neurological
symptoms, from the time of first assessment), presence of significant
extracranial injury, and primary presentation to the study hospitals.
Radiological variables were assessed from the first CT scan.
They included clot thickness, midline shift, patency of the basal
cisterns, presence of cranial fractures, and presence of concomitant
intracranial hemorrhage (subarachnoid hemorrhage, epidural he-
matoma, contralateral subdural hematoma, intraventricular hem-
orrhage, or intracerebral hematoma/contusion). We also noted if a
second preoperative CT scan was made, and whether it showed ra-
diological deterioration (i.e., presence of new focal lesion or >5 mm
increase in hematoma thickness).
Therapy-related variables included type of management (con-
servative or surgical), type of surgery (craniotomy, decompressive
craniectomy [DC], or other), use of an ICP monitor, and any de-
layed surgical procedures performed after the initial treatment was
received. The maximum diameter of the DC was measured from
postoperative CT scans. Patients were considered surgically treated
when a report was made on the indication and the surgical proce-
dure was started after the last CT performed in the emergency
room. Patients were considered conservatively managed when the
neurosurgeon on call said not to operate after the CT. Patients who
were primarily conservatively managed could require surgery later
on, after secondary deterioration.
All complications requiring medical attention during admission
(e.g., antibiotic treatment for infection) were noted. Complications
were defined as intracranial (e.g., seizure, hydrocephalus), cardio-
vascular (e.g., arrhythmia, ischemia), respiratory (e.g., respiratory
insufficiency, hypoxia), metabolic (e.g., electrolyte disturbances,
renal failure), infections (e.g., pneumonia, wound infection), or
other.



















































Outcome measures were mortality at discharge and functional
outcome according to the Glasgow Outcome Score (GOS). Func-
tional outcome was judged from outpatient follow-up letters at 3–9
months post-trauma, and dichotomized into favorable (GOS 4–5)
or unfavorable (GOS 1–3) categories.30
Two authors from region A collected all data. To ensure uniform
and unbiased collection, both contributors independently gathered
data according to a standardized collection sheet. In case of un-
certainty, variables were coded after consensus was reached through
discussion.
This study was approved by the ethics committees of the two
participating hospitals.
Statistical analysis
The median and interquartile range (IQR) were calculated for
continuous variables, and frequencies were reported along with
percentages for categorical variables. To test for differences in
patient characteristics, treatments, and outcomes between regions,
we used Pearson’s v2 test for categorical, and the Mann–Whitney
U test for continuous variables. In order to provide a summary
baseline prognostic score for both regions, a multivariable logistic
regression model, based on all available variables featured in
the Corticosteroid Randomization After Significant Head injury
(CRASH)-CT brain injury prognosis model (age, GCS score, pupil
reactivity to light, major extracranial injury, midline shift >5mm,
traumatic subarachnoid hemorrhage, and obliteration of the basal
cisterns), was used to calculate predicted probabilities for mor-
tality and unfavorable outcome.31
To assess the effect of treatment strategy on outcome, we used
region as a proxy for treatment strategy. That strategy correlates
with more surgeries (and possibly other aspects; see the Discussion
section). Assuming that regional variation was the only determinant
of treatment strategy, the region in which patients were treated was
used as grouping variable to compare outcomes. A multivariable
regression model was used to estimate the effect of treatment
strategy on outcome, adjusted for the confounders age, GCS score,
pupil reactivity, and hematoma thickness. In addition, subgroup
analysis restricted to patients with mild to moderate TBI (GCS 9–
15) was performed. The regression analyses were performed using
a multiple imputed data set created with the automatic imputation
method of the impute function of SPSS. Missing data were reported
for all variables at baseline. Results were considered statistically




A total of 612 cases were screened (n, region A = 294; n, region
B = 318) of which 195 cases met the eligibility criteria: 109 from
region A and 86 from region B. Five cases were excluded because of
severe comorbidity (n, region A = 1), or were deemed unsalvageable
(n, region B = 4) (Fig. 1).
The study population included 104 males (54.7%) and the me-
dian age was 68 years (IQR, 54–76). Regions did not differ sig-
nificantly on age, sex, use of anticoagulants, injury mechanism,
GCS score, occurrence of focal neurological symptoms, pupillary
examination, or frequency of major extracranial injury (Table 1).
Region A received more primary referrals than region B (63% vs.
21%, p < 0.01). Patients in region B more often experienced clinical
deterioration (34% vs. 51%, p < 0.01). Region A had larger median
hematoma thickness (14 mm vs. 10 mm, p < .01), larger median
midline shift (12 mm vs. 9 mm, p < 0.01), and fewer cranial frac-
tures (28% vs. 44%, p < 0.03). The baseline CRASH-CT-predicted
risk of unfavorable outcome was similar: 56% in region A and 53%
in region B ( p = 0.18). Missing values per variable used in both
univariable and multivariable regression analyses did not exceed
5.8% (Table 1).
FIG. 1. Patient inclusion flow chart showing the number of patients included in each region (region A: liberal surgical policy, region
B: more conservative policy) and the definitive treatment received (either primary surgical or conservative).




















































Patients in region A more often received emergency surgery
(84% vs. 65%, p < 0.01) or an ICP sensor (38% vs. 15%, p < 0.01).
When undergoing surgery, patients were more likely to undergo
DC in region B (32% vs. 55%, p < 0.01). The median size of DC in
region B was somewhat larger (110 mm vs. 116 mm, p = 0.15). Both
regions had a similar rate of delayed procedures (15% vs. 16%,
p = 0.57) and complications (Table 2).
The effect of treatment strategy
Hospital mortality in region A was 37%, compared with 45% in
region B ( p = 0.29). Also, in region A, 53% had an unfavorable
outcome after 3–9 months, compared with 62% in region B
( p = 0.23). Region showed a favorable effect for a more aggressive
treatment strategy (region A) in both unadjusted (mortality odds
ratio [OR], 0.75; 95% confidence interval [CI], 0.42–1.10; unfa-
vorable outcome OR, 0.74; 95% CI, 0.41–1.02) and adjusted
analysis (mortality OR, 0.43; 95% CI, 0.21–0.88; unfavorable
outcome OR, 0.53; 95% CI, 0.27–1.02). Subgroup analysis re-
stricted to patients with mild to moderate TBI (n = 110) showed a
similar effect for both mortality (adjusted OR, 0.34; 95% CI, 0.13–
0.91) and unfavorable outcome (adjusted OR, 0.33; 95% CI 0.14–
0.77) (Table 3). A post-hoc analysis with adjustment for DC and
primary referral confirmed the main results (Tables S1 and S2) (see
online supplementary material at http://www.liebertpub.com).
Table 1. Clinical and Radiological Variables for the Entire Study Population
Variable, % missing Region A (n = 108) Region B (n = 82) p value
Age, median (IQR), years, 0% 70 (54–78) 65 (53–74) 0.07
Male sex, no. (%), 0% 57/108 (53%) 47/82 (57%) 0.56
History of diabetes, no. (%), 1.6% 14/105 (13%) 10/82 (12%) 1.00
Vascular history, no. (%), 1.6% 60/105 (57%) 45/82 (55%) 0.769
Anticoagulant, no. (%), 1.6%
Anticoagulants 34/107 (32%) 18/80 (23%) 0.19
Platelet inhibitors 20/107 (20%) 16/80 (19%) 1.00
Mechanism of injury, no. (%), 2.5%
Fall 58/104 (56%) 45/81 (56%) 1.00
Assault 5/104 (5%) 1/81 (1%) 0.23
Motor vehicle accident 12/104 (12%) 13/81 (16%) 0.39
Fall from bicycle 12/104 (12%) 11/81 (14%) 0.82
Other 17/104 (16%) 11/81 (14%) 0.68
Primary presentation, no. (%), 0% 67/106 (63%) 17/82 (21%) <0.01
Focal neurological symptoms, no. (%), 24.7% 42/79 (53%) 28/64 (44%) 0.31
Abnormal pupils, no. (%), 5.3%
One 13/101 (13%) 12/79 (15%) 0.67
Two 14/101 (14%) 9/79 (12%) 0.66
First GCS score, median (IQR), 2.6% 9 (6–14) 12 (7–15) 0.48
Initial motor (M) score, median (IQR), 29.5% 6 (5–6) 5 (4–6) 0.04
TBI severity, no. (%), 1.6%
Mild (GCS 13–15) 40/107 (37%) 29/80 (36%) 1.00
Moderate (GCS 9–12) 18/107 (17%) 20/80 (25%) 0.20
Severe (GCS 3–8) 49/107 (46%) 31/80 (39%) 0.37
Clinical deterioration, no. (%), 0% 37/108 (34%) 44/82 (54%) <0.01
GCS score after deterioration, median (IQR), 5.2% 8 (4–13) 8 (5–13) 0.45
Major extracranial injury, no. (%), 3.2% 12/102 (12%) 11/82 (13%) 0.82
CT characteristics
Thickness, median (IQR), mm, 5.8% 14 (9–18) 10 (7–14) <0.01
Midline shift, median (IQR), mm, 4.2% 12 (7–16) 8 (3–13) <0.01
Basal cisterns obliterated, no. (%), 4.2% 39/101 (39%) 24/81 (30%) 0.22
Concomitant SAH, no. (%), 2.1% 24/104 (23%) 23/82 (28%) 0.50
Concomitant contusion, no. (%), 2.6% 20/104 (19%) 25/81 (31%) 0.08
Concomitant EDH, no. (%), 2.1% 7/104 (7%) 4/82 (5%) 0.76
Concomitant SDH, no. (%), 2.1% 8/104 (8%) 11/82 (13%) 0.23
Concomitant IVH, no. (%), 2.1% 2/104 (2%) 2/82 (2%) 1.00
Cranial fracture, no. (%), 2.1% 30/106 (28%) 35/80 (44%) 0.03
Second CT scan, no. (%), 1.6% 23/105 (22%) 19/82 (23%) 0.86
Radiological deterioration, 2.4% 14/22 (64%)a 10/19 (53%)a 0.54
Predicted unfavorable outcome based on CRASH-CT
variables (GOS £3, %), median (IQR), 12.6%
56% (42–75%) 53% (32–70%) 0.18
aPercentage of all second CT scans.
IQR, interquartile range; GCS, Glasgow Coma Scale; TBI, traumatic brain injury; CT, computed tomography; SAH, subarachnoid hemorrhage; EDH,
epidural hematoma; SDH, subdural hematoma; IVH, intraventricular hemorrhage; CRASH, Corticosteroid Randomization After Significant Head Injury;
GOS, Glasgow Outcome Score.



















































Effect of surgery on patient level
In multivariable analysis, surgery was associated with higher
odds of in-hospital mortality (OR, 6.6; 95% CI, 1.43–30.8) and
unfavorable outcome (OR, 1.56, 95% CI: 0.64–3.82, Table 4).
Discussion
This study compared an aggressive surgical policy to a more
conservative management strategy for traumatic ASDH. Although
the study groups were comparable in terms of baseline prognosis,
patients were significantly more likely to undergo emergency sur-
gery in the expected region. A primarily surgically focused strategy
was associated with a lower in-hospital mortality and unfavorable
outcome.
Estimating causal treatment effects in non-randomized data is
often impossible because of confounding by indication. Some of the
baseline imbalance can be corrected through stratification or mul-
tivariable modeling (among other selection or analysis techniques).
However, when we compared a surgical with a non-operative
treatment on patient level in this study (Table 4), in contrast to
comparing treatment strategies on a center level, emergency sur-
gery was associated with worse outcome even after adjusting for
confounders. This suggests unmeasured confounding by indication,
causing misleading effect estimates. The region-based comparison
is a major strength of this study. It allowed for a ‘‘natural ex-
periment’’ in which patients were ‘‘allocated’’ to one of both
policies based on where the accident occurred, and not based on
their baseline characteristics. This provided an opportunity for an
analysis that likely has a considerable reduction of unmeasured
Table 2. Hospital Course Variables for the Entire Study Population
Variable, % missing Region A (n = 108) Region B (n = 82) p values
ICP monitor placed, no. (%), 1.1% 40/106 (38%) 12/82 (15%) <0.01
Emergency surgery, 0%
Total, no. (%) 91/108 (84%) 53/82 (65%) <0.01
Craniotomy, no. (%) 60/91 (66%)a 24/53 (45%) a 0.02
DC, no. (%) 29/91 (32%)a 29/53 (55%) a <0.01
Other, no. (%) 2/91 (2%) a 0/53 (0%) a 0.53
Size of DC, median (IQR) 110 (97–115) 116 (103.5–127) 0.15
Delayed surgery, no. (%), 2.6%
Total 16/103 (15%) 16/82 (19%) 0.57
Craniotomy 4/16 (25%)a 7/15 (44%)a 0.46
DC 6/16 (38%)a 4/15 (25%)a 0.70
Burrhole 4/16 (25%)a 3/15 (19%)a 1.00
Other 2/16 (13%)a 2/15 (13%)a 1.00
Complications, no. (%), 7.4%
Total 56/95 (59%) 50/81 (62%) 0.76
Intracranial 30/95 (32%) 29/81 (36%) 0.63
Cardiovascular 13/95 (14%) 17/81 (21%) 0.23
Respiratory 4/95 (4%) 9/81 (11%) 0.15
Metabolic 3/95 (3%) 9/81 (11%) 0.07
Infection 30/95 (32%) 18/81 (22%) 0.18
Other 1/100 (1%) 7/81 (9%) 0.02
aPercentage within group of emergency or delayed procedures
ICP, intracranial pressure; IQR, interquartile range; DC, decompressive craniectomy








Univariable (n = 190),
OR (95% CI)
0.75 (0.42–1.10) 0.74 (0.41–1.02)
Multivariable (n = 190),
OR (95% CI)a
0.43 (0.21–0.88) 0.53 (0.27–1.02)
Subgroup of mild-moderate
TBI patients
Univariable (n = 110),
OR (95% CI)
0.51 (0.22–1.18) 0.45 (0.21–0.96)
Multivariable (n = 110),
OR (95% CI)b
0.34 (0.13–0.91) 0.33 (0.14–0.77)
Numbers are odds ratios and 95% confidence intervals for the effect of
treatment strategy on mortality and unfavorable outcome (Glasgow
Outcome Score £3).
aControlling for age, GCS score, pupillary reactivity, and hematoma
thickness.
bControlling for age, GCS score, and hematoma thickness.
OR, odds ratio; CI, confidence interval; TBI, traumatic brain injury;
GCS, Glasgow coma scale.







Effect of surgery on patient
level
Univariable, OR (95% CI) 9.7 (3.3–28.6) 3.5 (1.7–7.3)
Multivariable, OR (95% CI)a 6.6 (1.4–30.8) 1.6 (0.6–3.8)
Numbers are odds ratios and 95% confidence intervals for the effect of
surgery on mortality and unfavorable outcome (Glasgow Outcome Score £3).
aControlling for age, Glasgow Coma Scale score, pupillary reactivity
and hematoma thickness.
OR, odds ratio; CI, confidence interval



















































confounding compared with an analysis comparing the actual
treatment received. Based on the balance between groups with
regard to measured confounders, we may speculate that there is also
balance in unmeasured confounders. This assumption, however,
cannot be statistically proven (as would neither be possible nor
rational in an RCT).
A weakness is that we compared surgical strategy in only two
centers. It cannot be excluded that differences between regions in
other aspects of care; for example, other treatments or organization
of care, caused the difference in outcome in addition to the surgical
approach. To account for these differences in such a hospital-level
approach, more centers are generally needed to disentangle the care
aspects that correlate with the treatment decision of interest.
Therefore, we need to interpret our results with caution. The wide
CI of the effect estimates clearly underwrites this statement even
more. A study with more hospitals is needed to allow adjustment
for differences between the hospitals other than in the treatment of
interest.
An obvious limitation in this context, although inherent to the
observational nature, is that the region-based approach did not
completely eliminate all differences in baseline confounders. Pa-
tients from region A presented directly to the study hospital more
often (63% vs. 21%, p < 0.01). Primary presentation to a neuro-
surgical center improves patient outcome and has a close rela-
tionship with time to surgery,32 both of which may have contributed
to the lower rates of mortality and unfavorable outcome observed in
region A. The higher incidence of clinical deterioration in region B
may be consequent to the larger number of secondary referrals. On
the other hand, region B is characterized by relatively smaller he-
matoma thickness and midline shift (on the same time point CT),
while having a higher proportion of accompanying contusions.
However, the possible resulting confounding is adjusted for ap-
propriately. Moreover, apparently, the imbalances are evenly
spread out because the cohorts of both regions have a similar
prognosis in the validated CRASH model. Therefore, they were
similar for the most important predictors of outcome on arrival to
the study hospital.
Another limitation may be that the data collectors could not be
blinded for hospital of admission, which might give rise to infor-
mation bias. To minimize potential bias, a standardized and con-
trolled data collection protocol was followed. Nevertheless, we
need to consider that the GOS was estimated from clinic discharge
and visit letters, instead of a structured interview.
Further, this study needs an important note on generalizabil-
ity. This is a relatively elderly population, with a high proportion
of fall-related ASDH (56%). Recent comparable series of pa-
tients with ASDH of varying severities report mean ages of 55–58
years.19,33,34 The advanced age in this study should come as no
surprise considering the aging population in developed countries,
but should be kept in mind when applying its results. Also, for a
clinician to determine to which patients these results are relevant
she/he needs to consider for what kind of ASDH patients neuro-
surgery is consulted in the Netherlands. An unknown number of
mild cases reviewed by the neurologist or neurology resident
without consultation of a neurosurgeon were not included. This
explains the relatively small number of conservatively treated pa-
tients (24% overall) in our cohort compared with recent studies,
reporting 74–83% of ASDHs being treated nonoperatively.33,34
And, although much less common, this also applies to very severe
cases, not operated on because of an extremely poor prognosis.
Because the mild cases constitute the majority of TBIs, and this
patient category undoubtedly has an above-average prognosis,
applying the favorable results of surgery to all ASDH patients
would not be reasonable. Although both the age and consultation
patterns might influence the generalizability, we nonetheless con-
sider the current selection useful in research on surgical decision
making, because our cohort is representative of the ASDH popu-
lation currently presented to neurosurgeons.
Role of surgery for ASDH
Our results are in line with other recent studies reporting a
positive effect of early/aggressive surgical management, mainly for
severe TBI, on mortality and functional outcome.15,35 A recent
report showed that this could also be true for routine use of invasive
ICP measurement for severe TBI.14 On the other hand, when re-
stricting to surgery, and the complete patient domain; that is, ASDH
patients with mild to severe TBI, previous studies have reported
worse or similar outcomes in patients undergoing surgical treat-
ment.24–26,32,36,37 However, all studies compared outcomes be-
tween surgically and non-operatively treated patients at the patient
level rather than at a regional level, potentially leading to con-
founding by indication, because more severely injured patients are
more likely to be operated on. As mentioned, when performing a
conventional analysis on our cohort, surgery was associated with
increased mortality and unfavorable outcome in our data. Hence,
the distorting effect of confounding by indication in TBI supports
the use of a comparative effectiveness approach when an RCT is
not feasible for whatever reason.
When discussing the role of surgery in TBI, the use of DC cannot
be left unmentioned. Region B used DC significantly more often,
despite equal distribution of prognostic factors. This could reflect
another variation in surgical strategy or be consequent to the higher
number of secondary referrals, resulting in presentation at a later
stage, when brain swelling has started to occur. There is limited
evidence on the use of primary DC in the treatment of ASDH, and
studies comparing craniotomy with DC are likely confounded by
indication as well.38–40 Consequently, the effect of more frequent
use of DC in region B on our outcome measures is uncertain. The
planned Randomised Evaluation of Surgery with Craniectomy for
Patients Undergoing Evacuation for ASDH (RESCUE-ASDH) trial
will use an experimental comparative effectiveness design to
clarify the value of DC as a primary treatment in severe TBI.11
This study reports an example of the practice variation in sur-
gical treatment of traumatic ASDH. Advantage can be taken of this
variation for CER. Larger cohorts with more hospitals are required
to perform robust analyses to explore the ability of this method to
infer causality, and with enough statistical power to study specific
substrata according to age and trauma severity. The availability of such
cohorts, with prospectively gathered, trial- quality data from real-world
settings, will allow initiatives such as Neuro-traumatology Quality
Registry (Net-QuRe) and Collaborative European NeuroTrauma Ef-
fectiveness Research in Traumatic Brain Injury (CENTER-TBI) to
answer urgent clinical questions to provide the much needed guidance
for the treatment of TBI.41
Conclusion
In this comparative study of surgery for ASDH, an aggressive
management strategy favoring emergency evacuation of the he-
matoma was associated with better outcome. This conclusion de-
rives from a contemporary cohort of relatively elderly traumatic
ASDH patients that reflects the current population presented to a
neurosurgeon. Larger, prospective, comparative studies with more



















































hospitals are needed to confirm this effect of surgery and to explore
generalizability.
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